Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score
- PMID: 36460308
- PMCID: PMC9723953
- DOI: 10.1136/openhrt-2022-002143
Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score
Abstract
Objectives: Our aim was to derive, based on the SWEDEHEART registry, and validate, using the Western Denmark Heart registry, a patient-oriented risk score, the SweDen score, which could calculate the risk of 1-year mortality following a myocardial infarction (MI).
Methods: The factors included in the SweDen score were age, sex, smoking, diabetes, heart failure and statin use. These were chosen a priori by the SWEDEHEART steering group based on the premise that the factors were information known by the patients themselves. The score was evaluated using various statistical methods such as time-dependent receiver operating characteristics curves of the linear predictor, area under the curve metrics, Kaplan-Meier survivor curves and the calibration slope.
Results: The area under the curve values were 0.81 in the derivation data and 0.76 in the validation data. The Kaplan-Meier curves showed similar patient profiles across datasets. The calibration slope was 1.03 (95% CI 0.99 to 1.08) in the validation data using the linear predictor from the derivation data.
Conclusions: The SweDen risk score is a novel tool created for patient use. The risk score calculator will be available online and presents mortality risk on a colour scale to simplify interpretation and to avoid exact life span expectancies. It provides a validated patient-oriented risk score predicting the risk of death within 1 year after suffering an MI, which visualises the benefit of statin use and smoking cessation in a simple way.
Keywords: acute coronary syndrome; biostatistics; myocardial infarction.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures



Similar articles
-
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9. Lancet. 2021. PMID: 33711294
-
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study.Lancet Digit Health. 2022 Jan;4(1):e37-e45. doi: 10.1016/S2589-7500(21)00228-4. Lancet Digit Health. 2022. PMID: 34952674
-
Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).J Am Heart Assoc. 2015 Jul 14;4(7):e001995. doi: 10.1161/JAHA.115.001995. J Am Heart Assoc. 2015. PMID: 26175358 Free PMC article.
-
Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study.Eur J Prev Cardiol. 2017 Apr;24(6):639-646. doi: 10.1177/2047487317693951. Epub 2017 Jan 1. Eur J Prev Cardiol. 2017. PMID: 28195516 Free PMC article.
-
Statins in the prevention of heart failure after myocardial infarction.Curr Heart Fail Rep. 2009 Dec;6(4):215-9. doi: 10.1007/s11897-009-0030-8. Curr Heart Fail Rep. 2009. PMID: 19948089 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical